Y
Yaojie Wu
Publications - 4
Citations - 1006
Yaojie Wu is an academic researcher. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 2, co-authored 2 publications receiving 859 citations.
Papers
More filters
Journal ArticleDOI
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.
Wei Tang,Zhujun Cao,Mingfeng Han,Zhengyan Wang,Junwen Chen,Wenjin Sun,Yaojie Wu,Wei Xiao,Shengyong Liu,Erzhen Chen,Wei Chen,Xiongbiao Wang,Jiuyong Yang,Jun Lin,Qingxia Zhao,Youqin Yan,Zhibin Xie,Dan Li,Yaofeng Yang,Leshan Liu,Jieming Qu,Guang Ning,Guochao Shi,Qing Xie +23 more
TL;DR: Administration of hydroxychloroquine did not result in a significantly higher probability of negative conversion than standard of care alone in patients admitted to hospital with mainly persistent mild to moderate covid-19, and adverse events were higher in hydroxy chloroquine recipients than in non-recipients.
Posted ContentDOI
Hydroxychloroquine in patients mainly with mild to moderate COVID–19: an open–label, randomized, controlled trial
Wei Tang,Zhujun Cao,Mingfeng Han,Zhengyan Wang,Junwen Chen,Wenjin Sun,Yaojie Wu,Wei Xiao,Shengyong Liu,Erzhen Chen,Wei Chen,Xiongbiao Wang,Jiuyong Yang,Jun Lin,Qingxia Zhao,Youqin Yan,Zhibin Xie,Dan Li,Yaofeng Yang,Leshan Liu,Jieming Qu,Guang Ning,Guochao Shi,Qing Xie +23 more
TL;DR: The administration of HCQ did not result in a higher negative conversion rate but more alleviation of clinical symptoms than SOC alone in patients hospitalized with COVID-19 without receiving antiviral treatment, possibly through anti-inflammatory effects.
Journal ArticleDOI
Efficacy and Safety of Complementary Therapy With Jing Si Herbal Tea in Patients With Mild-To-Moderate COVID-19: A Prospective Cohort Study
TL;DR: Jing-Si Herbal Tea combined with standard management more effectively reduced the SARS-CoV-2 viral load and systemic inflammation and alleviated lung infiltrates in the patients with mild-to-moderate COVID-19, especially in the male and older patients (those aged ≥60 years).
Journal ArticleDOI
Immunothrombosis biomarkers as potential predictive factors of acute respiratory distress syndrome in moderate-to-critical COVID-19: A single-center, retrospective cohort study
Giou Teng Yiang,Yaojie Wu,Kuo-Wang Tsai,I-Shiang Tzeng,Wan-Chung Hu,Min Tser Liao,Kuo Cheng Lu,HsuehWen Chung,You Chen Chao,Wen Lin Su +9 more
TL;DR: In this article , the authors investigated the clinical correlation between immunothrombosis biomarkers (including tissue factor [TF] and von Willebrand factor [vWF]) and coronavirus disease 2019 (COVID-19)-related ARDS.